1st Quarter - Report

PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION

Period 1st Quarter 2025 Filed Apr 21, 2025 Signed by Jonathan Heafitz

Official filing
Firm
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
Client
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
Income
—
Expenses
$4,112,554
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act

LobbyistCovered position, as disclosed
ANTHONY BUSH New Legislative Assistant, House Committee on Oversight and Reform, Majority Staff Research Assistant, House Committee on Oversight and Reform, Majority Staff Personal Assistant to Rep. Elijah Cummings
JONATHAN M HEAFITZ —
LUCIA LEBENS —
JUAN CARLOS SCOTT —
EMILY THREADGILL —

Contacted: Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1095 (119th), H.R. 2041 (119th), S. 864 (119th), S. 1040 (119th), H.R. 950 (119th), S. 832 (119th), H.R. 2214 (119th), S. 882 (119th), S. 2484 (119th), S. 1302 (119th), H.R. 2450 (119th), S. 527 (119th), S. 526 (119th), S. 1041 (119th), H.R. 1968 (119th), S. 927 (119th)

Health Issues HCR

H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act

LobbyistCovered position, as disclosed
ANTHONY BUSH Legislative Assistant, House Committee on Oversight and Reform, Majority Staff Research Assistant, House Committee on Oversight and Reform, Majority Staff Personal Assistant to Rep. Elijah Cummings
JONATHAN M HEAFITZ —
LUCIA LEBENS —
JUAN CARLOS SCOTT —
EMILY THREADGILL —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Bills named: S. 1041 (119th), S. 1095 (119th), S. 2484 (119th), H.R. 950 (119th), S. 864 (119th), S. 1040 (119th), H.R. 1968 (119th), H.R. 2214 (119th), S. 527 (119th), H.R. 2450 (119th), S. 882 (119th), H.R. 2041 (119th), S. 1302 (119th), S. 526 (119th), S. 832 (119th), S. 927 (119th)

Pharmacy PHA

H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act

LobbyistCovered position, as disclosed
ANTHONY BUSH Legislative Assistant, House Committee on Oversight and Reform, Majority Staff Research Assistant, House Committee on Oversight and Reform, Majority Staff Personal Assistant to Rep. Elijah Cummings
JONATHAN M HEAFITZ —
LUCIA LEBENS —
JUAN CARLOS SCOTT —
EMILY THREADGILL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: S. 1302 (119th), S. 832 (119th), H.R. 1968 (119th), H.R. 2450 (119th), H.R. 2214 (119th), H.R. 2041 (119th), S. 1041 (119th), S. 864 (119th), S. 2484 (119th), S. 1095 (119th), S. 527 (119th), S. 927 (119th), S. 1040 (119th), S. 882 (119th), H.R. 950 (119th), S. 526 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.